These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4445451)

  • 21. Plasma catecholamines and vascular reactivity in uremic and dialysis patients.
    Campese VM; Iseki K; Massry SG
    Contrib Nephrol; 1984; 41():90-8. PubMed ID: 6525874
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma catecholamine and dopamine -hydroxylase amounts in phaeochromocytoma.
    Geffen LB; Rush RA; Louis WJ; Doyle AE
    Clin Sci; 1973 Apr; 44(4):421-4. PubMed ID: 4699319
    [No Abstract]   [Full Text] [Related]  

  • 23. MAO, DBH and COMT: the effect of anxiety.
    Mathew RJ; Ho BT; Kralik P; Taylor D; Claghorn JL
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):25-8. PubMed ID: 7440522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine-beta-hydroxylase activity and catecholamine levels in the plasma of patients with renal failure.
    Ksiazek A
    Nephron; 1979; 24(4):170-3. PubMed ID: 492427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine-beta-hydroxylase deficiency in humans.
    Biaggioni I; Goldstein DS; Atkinson T; Robertson D
    Neurology; 1990 Feb; 40(2):370-3. PubMed ID: 2300263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of therapy for mild hypertension on circulating level of dopamine beta-hydroxylase.
    Grant C; Routh JI; Lawton W; Witte DL
    Clin Chim Acta; 1976 Jun; 69(2):333-40. PubMed ID: 1277563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of ganglionic blockade, reserpine and vinblastine on plasma catecholamines and dopamine-beta-hydroxylase in the rat.
    Reid JL; Kopin IJ
    J Pharmacol Exp Ther; 1975 Jun; 193(3):748-56. PubMed ID: 50436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma dopamine-beta-hydroxylase activity in depressed patients: role of treatment.
    Damase-Michel C; Schmitt L; Le Quang B; Bagheri H; Montastruc JL; Moron P
    J Neurol Neurosurg Psychiatry; 1991 Aug; 54(8):749. PubMed ID: 1940956
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of beta-adrenergic blockade on circulating catecholamines and dopamine-beta-hydroxylase activity during exercise in normal subjects.
    Sheehan MW; Brammell HL; Sable DL; Nies AS; Horwitz LD
    Am Heart J; 1983 May; 105(5):777-82. PubMed ID: 6303097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of glucocorticoids on plasma catecholamines in depression.
    Rupprecht R; Rupprecht M; Rupprecht C; Sofic E; Barocka A; Beck G; Noder M; Riederer P
    Psychiatry Res; 1989 Aug; 29(2):187-98. PubMed ID: 2798597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in human plasma catecholamines and dopamine-beta-hydroxylase produced by prostaglandin F2 alpha.
    Mueller RA; Fishburne JI; Brenner WE; Braaksma JT; Staurovsky LG; Hoffer JL; Hendricks CH
    Prostaglandins; 1972 Sep; 2(3):219-26. PubMed ID: 4653736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Increased plasma noradrenaline values in severe atopic eczema].
    Ionescu G; Kiehl R
    Z Hautkr; 1989 Nov; 64(11):1036-7. PubMed ID: 2609712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isotope-derivative measurements of plasma norepinephrine and epinephrine in man.
    Cryer PE
    Diabetes; 1976 Nov; 25(11):1071-82. PubMed ID: 825406
    [No Abstract]   [Full Text] [Related]  

  • 34. Improved liquid chromatographic determination of dopamine-beta-hydroxylase activity in tissues and plasma.
    Racz K; Kuchel O; Debinski W; Buu NT
    J Chromatogr; 1986 Oct; 382():117-25. PubMed ID: 3782380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chemical sympathectomy on the increases in plasma catecholamines and dopamine-beta-hydroxylase induced by forced immobilization and insulin-induced hypoglycemia: origin and fate of plasma dopamine-beta-hydroxylase.
    Israel AS; Barbella YR; Cubeddu LX
    J Pharmacol Exp Ther; 1982 Jun; 221(3):577-83. PubMed ID: 7045331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine study of the mechanism of action of electroconvulsive therapy.
    Arató M; Bagdy G
    Neuropsychobiology; 1982; 8(3):162-8. PubMed ID: 7078718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effects of dopamine administration on plasma catecholamine and serum dopamine-beta-hydroxylase levels during general anesthesia].
    Tsuda K; Oda M; Saito N; Kurashiki T; Nobuhara H; Totsuka Y; Nakayama M; Urabe T; Tanaka A; Sato T
    Masui; 1986 Dec; 35(12):1816-23. PubMed ID: 3560410
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma catecholamines and ECT.
    Khan A; Nies A; Johnson G; Becker J
    Biol Psychiatry; 1985 Jul; 20(7):799-804. PubMed ID: 4005337
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute effects of single and repeated electroconvulsive therapy on plasma catecholamines and blood pressure in major depressive disorder.
    Mann JJ; Manevitz AZ; Chen JS; Johnson KS; Adelsheimer EF; Azima-Heller R; Massina A; Wilner PJ
    Psychiatry Res; 1990 Nov; 34(2):127-37. PubMed ID: 2287647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroconvulsive therapy: effect on catecholamine excretion by psychiatric patients.
    Messiha FS; Turek I
    Res Commun Chem Pathol Pharmacol; 1970 Jul; 1(4):535-46. PubMed ID: 5524262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.